968-50788-35959
3 vaccinations
4 coded responses
24 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 240 / VA
- Registered
- 2022-10-20
- Relationship
- Child or adolescent in my care
- Guardian
- Y9G-58885-35728
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-07
Dose 1 — Pfizer-BioNTechCo-administered: Chickenpox:Flu:MMR:Other
-
2022-10-20
Registered in v-safe
- 2022-10-20
- 2022-10-21
- 2022-10-28
-
2022-11-01
Dose 2 — Pfizer-BioNTech
-
2022-11-05
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: PoorFree text: Cold symptoms runny nose and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-11-06
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: FairFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-11-07
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: Fair · Irritability/cryingFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-11-08
Survey response — day 7, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Still has a runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-11-15
- 2022-11-22
- 2022-11-29
- 2022-12-06
- 2022-12-13
- 2023-02-02
-
2023-04-13
Dose 3 — Pfizer-BioNTech
- 2023-04-13
- 2023-04-14
- 2023-04-17
- 2023-04-18
-
2023-04-19
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Fair · Irritability/crying, Loss of appetite, DiarrheaUnder 3 check-in
-
2023-04-20
Health check-in — day 7, dose 3, under 3Feeling: Good · Rash, not including the immediate area around the injection siteUnder 3 check-in
- 2023-04-27
- 2023-05-04
- 2023-05-11
- 2023-05-18
- 2023-05-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-07 | Pfizer-BioNTech | Chickenpox:Flu:MMR:Other |
| 2 | 2022-11-01 | Pfizer-BioNTech | No |
| 3 | 2023-04-13 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Cold symptoms runny nose and cough
Systemic reaction (other): Runny nose and cough
Systemic reaction (other): Cold symptoms
Release 12 (Under 3) — day 7, dose 2, under 3
Systemic reaction (other): Still has a runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release